0001415889-22-000324.txt : 20220104
0001415889-22-000324.hdr.sgml : 20220104
20220104212857
ACCESSION NUMBER: 0001415889-22-000324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220102
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chapman Steven Leonard
CENTRAL INDEX KEY: 0001711968
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 22509100
MAIL ADDRESS:
STREET 1: 201 INDUSTRIAL ROAD, SUITE 410
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-01042022_060149.xml
X0306
4
2022-01-02
0001604821
Natera, Inc.
NTRA
0001711968
Chapman Steven Leonard
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
true
false
false
CEO AND PRESIDENT
Common Stock
2022-01-02
4
M
0
3125
A
48740
D
Common Stock
2022-01-03
4
M
0
3052
9.29
A
51792
D
Common Stock
2022-01-03
4
M
0
4072
13.01
A
55864
D
Common Stock
2022-01-03
4
M
0
2084
20.27
A
57948
D
Common Stock
2022-01-03
4
M
0
18750
25.46
A
76698
D
Common Stock
2022-01-03
4
S
0
2260
86.2154
D
74438
D
Common Stock
2022-01-03
4
S
0
12890
87.8182
D
61548
D
Common Stock
2022-01-03
4
S
0
10005
88.4361
D
51543
D
Common Stock
2022-01-03
4
S
0
1493
89.2864
D
50050
D
Common Stock
2022-01-03
4
S
0
1310
90.8283
D
48740
D
Common Stock
2022-01-03
4
S
0
1209
91.52
D
47531
D
Restricted Stock Unit
2022-01-02
4
M
0
3125
0
D
Common Stock
3125
12500
D
Stock Option (right to buy)
9.29
2022-01-03
4
M
0
3052
0
D
2028-03-08
Common Stock
3052
9158
D
Stock Option (right to buy)
13.01
2022-01-03
4
M
0
4072
0
D
2029-01-10
Common Stock
4072
25095
D
Stock Option (right to buy)
20.27
2022-01-03
4
M
0
2084
0
D
2029-04-11
Common Stock
2084
31250
D
Stock Option (right to buy)
25.46
2022-01-03
4
M
0
18750
0
D
2030-03-26
Common Stock
18750
0
D
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2021, as amended on May 14, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.73 to $86.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.11 to $88.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.11 to $89.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.12 to $89.61 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.70 to $91.10 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1.
The RSUs vest over four years. 25% of the RSUs vested on January 2, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
The option became exercisable upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving
certain milestones relating to the Issuer's stock price.
/s/ Tami Chen, Attorney-in-Fact
2022-01-04